Bliss GVS Pharma Limited — Others, 29-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bliss GVS Pharma Limited has announced a board meeting to discuss key operational updates, including a certificate confirming the completion of dematerialization for the quarter ended December 31, 2024. This update signifies effective management of share dematerialization, crucial for shareholder confidence and streamlined operations. The company’s ability to facilitate this process smoothly may enhance investor sentiment by reflecting a strong governance framework. Overall, this development could point towards a positive outlook for the company's operational efficiencies and shareholder value.